Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21569999

Download in:

View as

General Info

PMID
21569999